Skip to main content
SpringerLink
Log in

CD160

  • Reference work entry
  • First Online:
Encyclopedia of Signaling Molecules

  • 72 Accesses

Synonyms

BY55

Historical Background

NK lymphocytes recognize abnormal or aberrant cells through multiple receptors that detect normal host molecules, as well as stress-induced or pathogen-expressed motifs (Lanier 2005; Long et al. 2013). Individual NK cells express both activating and inhibitory receptors, which together drive the specificity towards target cells.

The NK cell inhibitory receptors have been classified into three groups, namely, the heterodimeric CD94/NKG2A, the Ig-like transcript (ILT) receptors, and the members of the killer cell Ig-like receptors (KIRs). All of them bind to classical or nonclassical MHC-class I molecules. A common characteristic of the inhibitory receptors is the presence of immunoreceptor tyrosine-based inhibition motif(s) (ITIM) within their intracellular tail. Following engagement by their ligands, the inhibitory receptors become phosphorylated on the tyrosine residue(s) present in the ITIM(s), creating docking sites for the SH2-domains of the...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abecassis S, Giustiniani J, Meyer N, Schiavon V, Ortonne N, Campillo JA, et al. Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation. J Invest Dermatol. 2007;127:1161–6. https://doi.org/10.1038/sj.jid.5700680.

    Article  PubMed  CAS  Google Scholar 

  • Agrawal S, Marquet J, Freeman GJ, Tawab A, Bouteiller PL, Roth P, et al. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol. 1999;162:1223–6.

    PubMed  CAS  Google Scholar 

  • Anumanthan A, Bensussan A, Boumsell L, Christ AD, Blumberg RS, Voss SD, et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol. 1998;161:2780–90.

    PubMed  CAS  Google Scholar 

  • Arnon TI, Markel G, Mandelboim O. Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol. 2006;16:348–58. https://doi.org/10.1016/j.semcancer.2006.07.005.

    Article  PubMed  CAS  Google Scholar 

  • Barakonyi A, Rabot M, Marie-Cardine A, Aguerre-Girr M, Polgar B, Schiavon V, et al. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J Immunol. 2004;173:5349–54.

    Article  PubMed  CAS  Google Scholar 

  • Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol. 2008;9:176–85. https://doi.org/10.1038/ni1554.

    Article  PubMed  CAS  Google Scholar 

  • Chabot S, Jabrane-Ferrat N, Bigot K, Tabiasco J, Provost A, Golzio M, et al. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med. 2011;208:973–86. https://doi.org/10.1084/jem.20100810.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • El-Far M, Pellerin C, Pilote L, Fortin JF, Lessard IA, Peretz Y, et al. CD160 isoforms and regulation of CD4 and CD8 T-cell responses. J Transl Med. 2014;12:217. https://doi.org/10.1186/s12967-014-0217-y.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fons P, Chabot S, Cartwright JE, Lenfant F, L'Faqihi F, Giustiniani J, et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood. 2006;108:2608–15. https://doi.org/10.1182/blood-2005-12-019919.

    Article  PubMed  CAS  Google Scholar 

  • Giustiniani J, Alaoui SS, Marie-Cardine A, Bernard J, Olive D, Bos C, et al. Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in Paroxysmal Nocturnal Hemoglobinuria. Curr Mol Med. 2012;12;188–98. doi:http://www.eurekaselect.com/76105/article#.

    Google Scholar 

  • Giustiniani J, Marie-Cardine A, Bensussan A. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J Immunol. 2007;178:1293–300.

    Article  PubMed  CAS  Google Scholar 

  • Giustiniani J, Bensussan A, Marie-Cardine A. Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J Immunol. 2009;182:63–71.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez S, Groh V, Spies T. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol. 2006;298:121–38.

    PubMed  CAS  Google Scholar 

  • Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225–74. https://doi.org/10.1146/annurev.immunol.23.021704.115526.

    Article  CAS  PubMed  Google Scholar 

  • Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 1998;8:693–701.

    Article  PubMed  CAS  Google Scholar 

  • Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci U S A. 2002;99:16963–8. https://doi.org/10.1073/pnas.012681099.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: Integration of signals for activation and inhibition. Annu Rev Immunol. 2013;31:227–58. https://doi.org/10.1146/annurev-immunol-020711-075005.

    Article  PubMed  CAS  Google Scholar 

  • Maeda M, Carpenito C, Russell RC, Dasanjh J, Veinotte LL, Ohta H, et al. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J Immunol. 2005;175:4426–32.

    Article  PubMed  CAS  Google Scholar 

  • Maiza H, Leca G, Mansur IG, Schiavon V, Boumsell L, Bensussan A. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med. 1993;178:1121–6.

    Article  PubMed  CAS  Google Scholar 

  • Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol Today. 2000;21:228–34.

    Article  PubMed  CAS  Google Scholar 

  • Nikolova M, Marie-Cardine A, Boumsell L, Bensussan A. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int Immunol. 2002;14:445–51.

    Article  PubMed  CAS  Google Scholar 

  • Nikolova M, Lelievre JD, Carriere M, Bensussan A, Levy Y. Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. Blood. 2009;113:4556–65. https://doi.org/10.1182/blood-2008-04-151407.

    Article  PubMed  CAS  Google Scholar 

  • Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 1997;158:5083–6.

    PubMed  CAS  Google Scholar 

  • Ortonne N, Ram-Wolff C, Giustiniani J, Marie-Cardine A, Bagot M, Mecheri S, et al. Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160. J Invest Dermatol. 2011;131:916–24. https://doi.org/10.1038/jid.2010.412.

    Article  PubMed  CAS  Google Scholar 

  • Rabot M, El Costa H, Polgar B, Marie-Cardine A, Aguerre-Girr M, Barakonyi A, et al. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment. Int Immunol. 2007;19:401–9. https://doi.org/10.1093/intimm/dxm005.

    Article  PubMed  CAS  Google Scholar 

  • Sako N, Schiavon V, Bounfour T, Dessirier V, Ortonne N, Olive D, et al. Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin. Cytometry A. 2014;85:869–82. https://doi.org/10.1002/cyto.a.22512.

    Article  PubMed  CAS  Google Scholar 

  • Sedy JR, Bjordahl RL, Bekiaris V, Macauley MG, Ware BC, Norris PS, et al. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells. J Immunol. 2013;191:828–36. https://doi.org/10.4049/jimmunol.1300894.

    Article  PubMed  CAS  Google Scholar 

  • Tu TC, Brown NK, Kim TJ, Wroblewska J, Yang X, Guo X, et al. CD160 is essential for NK-mediated IFN-gamma production. J Exp Med. 2015;212:415–29. https://doi.org/10.1084/jem.20131601.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 1998;187:2065–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science. 2004;306:1517–9. https://doi.org/10.1126/science.1103478.

    Article  PubMed  CAS  Google Scholar 

  • Welte S, Kuttruff S, Waldhauer I, Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol. 2006;7:1334–42. https://doi.org/10.1038/ni1402.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. INSERM U976, Saint Louis Hospital, 1 Avenue Claude Vellefaux, 75475, Paris, cedex 10, France

    Armand Bensussan & Anne Marie-Cardine

Authors
  1. Armand Bensussan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Marie-Cardine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Armand Bensussan .

Editor information

Editors and Affiliations

  1. Department of Molecular Science and Technology, Ajou University, Suwon, Korea

    Sangdun Choi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Bensussan, A., Marie-Cardine, A. (2018). CD160. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_31

Download citation

Publish with us

Policies and ethics

Search

Navigation